Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* No medical, psychiatric, or sleep disorders~* Ability to provide written informed consent~Exclusion Criteria:~* Lifetime history of night shift work~* Evidence of any sleep disorder~* Psychiatric or neurological disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).